What You’ll Discover in Karen M. Marzlin Cardiac Medications Management of Complex Cardiovascular Disorders
- Faculty:
- Karen M. Marzlin
- Duration:
- Full Day
- Format:
- Audio and Video
- Copyright:
- Mar 11, 2016
Description
Join Karen M. Marzlin, DNP. RN. CCNS. CCRN.-CMC, CHFN for an informative and practical day focusing on common types of You can see cardiac conditions in your practice and the current medications that are used to treat them.
Three decades of drawing of Experience treating patients with cardiology Karen We will supply you with cutting-edge information-Information about the selection of You will learn about the side effects and interactions of certain cardiac medications. With this understanding, you will be able to leave the meeting with clear goals of The physiological basis of cardiovascular drug therapy. Drugs used to alter hemodynamic parameters, alter cardiac electrical system, stop the clotting process and treat various conditions. of Heart disease.
Don’t miss this opportunity to keep pace with the ever-Changes in the field of Cardiac care can be improved through the use of the information from this seminar to reduce the risk. of Potential adverse effects for your patients With this holistic perspective, you will leave the clinic with a better understanding of your patients. of Cardiovascular pharmacology, and how it can help your patient achieve better outcomes and greater quality of life.
Â
Â
ADA requirements
We will be glad to accommodate your ADA requests. Call our Customer Service Department at 1-866-992-0011 for more information.-800-844-8260.
Satisfaction Guarantee
Our goal is to ensure your satisfaction. You can reach us at PO Box 1000 Eau Claire, WI 54702 with any questions.-Call 1 or 1000-800-844-8260.
Handouts
| Webcast Manual (7.56 MB) | 61 pages | Available after Purchase |
Outline
Hemodynamics and Shock
- Physiological determinants of Performance of myocardium
- Vasodilators
- Vasopressors
- Inotropes
- Shock: Dopamine versus Norepinephrine
- Nuances of decompensated heart failure
Risk Factor Optimization
- Statin therapy in primary and secondary prevention
- Other Antilipid agents: when to use what?
- Trials of lipid-lowering agents with positive outcomes
- AIM High
- Thrive
- There are many options for hypertension drugs
- Resistant hypertension
Atrial Fibrillation
- Antiarrhythmic pharmacology for rate control
- Antiarrhythmic pharmacology for rhythm control
- Clinical implications of potassium channel blockers
- Special considerations for Dronedarone and Amiodarone
- Options for anticoagulant medication
- Fibrinolytics
- Anticoagulants
- Antiplatelets
Therapeutic Advances in Acute Coronary Syndrome
- Prasugrel
- Ticagrelor
- Epleranone post-STEMI
- Non-Steroidals
- ASA and CABG
- Contrast nephropathy
Heart Failure
- Optimal loop diuretic dosage / route of Administration
- Nesiritide
- OPTIMEÂ Trial
- Serelaxin
- RAASÂ drugs
- The evidence-Beta-blockers that are based
- Systolic dysfunction: No drugs
The Patient: Putting it all together-A Centered Approach to Pharmacy and Prescribing
Faculty
Karen M. Marzlin, DNP. RN. CCNS. CCRN.-CMC Similar seminars and products 5
Acute Care Clinical Nurse Specialist/Co-Owner
Key Choice
Karen M. Marzlin, DNP. RN. CCNS. CCRN.-CMC, CHFNAcute care Clinical Nurse Specialist, assisting patients with medical cardiology in a 56-CCU for bed variable staffing Karen She has been a nurse for more than 26 years, and her entire career has been spent caring for cardiac patients. Karen Also dedicated for 10 years of She has a career in cardiovascular program administration and management. Her passion for excellence at the bedside is apparent in her daily practice.
KarenIn addition to keeping a portion,-Time clinical practice is a co-Owner of Key Choice is a training and consulting company. She provides continuing education and travels across the country. of cardiovascular and critical care topics as well as leadership/management consulting. Her presentations are lively and provide practical tips to help patients achieve excellence at their bedside. It is important to connect knowledge with practice. of Each education program.
Karen Collaboration on Cardiovascular Nursing Practice: A Comprehensive Nursing Resource Manual Published by CNEA, 2007.
Speaker Disclosures
Financial: Karen Marzlin PESI, Inc. gives a speaking honourarium
Nonfinancial: Karen Marzlin Does not have any relevant nonfinancial relationships to disclose.
Online Viewing or Digital Download | Online Viewing or Digital Download | Karen M. Marzlin – Cardiac Medications – Management of Complex Cardiovascular Disorders
IMPORTANT: This is the entire “Karen M. Marzlin – Cardiac Medications – Management of Complex Cardiovascular Disorders” It is totally Downloadable And Available In your account
(In case of If your link is broken, we will renew it as soon as possible.
We are grateful for your patience.
